Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667507 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Aqueous Dexamethasone
A Phase 4 study of Pharmacokinetics and Aqueous Dexamethasone, sponsored by Frank A. Bucci, Jr., M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT04667507: Completed Phase 4 study of Pharmacokinetics and Aqueous Dexamethasone, sponsored by Frank A. Bucci, Jr., M.D..
NCT04667507 is a Phase 4 study of Pharmacokinetics and Aqueous Dexamethasone that has completed, run by Frank A. Bucci, Jr., M.D.. The registered enrollment target is 102 participants, above the 59-participant average among 37 other Pharmacokinetics trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04667507, a Phase 4 study of Pharmacokinetics and Aqueous Dexamethasone, has completed, sponsored by Frank A. Bucci, Jr., M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.
Primary Outcome
Concentration of dexamethasone in the aqueous humor will be determined by an independent laboratory using standardized high-pressure liquid chromatography and mass spectrometry assasys. Pharmacokinetic parameters determined from aqueous humor concentration will minimally include maximum concentration (Cmax).
Conditions Studied
Interventions
- DRUG Dexamethasone Ophthalmic implant
Study Locations (1)
Pennsylvania
- Bucci Laser Vision - Wilkes-Barre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-06-22 |
| Phase | Phase 4 |
What the finished NCT04667507 record still lists
NCT04667507 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, above the 59-participant average among 37 other Pharmacokinetics trials with a reported enrollment target (73% higher).
The record links to 3 conditions, with Pharmacokinetics appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone Ophthalmic implant is the first listed.
NCT04667507 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04667507 about?
NCT04667507 is a clinical study titled "Pharmacokinetics of Aqueous Dexamethasone". The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.
What is the current status of trial NCT04667507?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2021-01-01. Estimated completion is 2022-06-22.
What conditions does trial NCT04667507 study?
This clinical trial studies the following conditions: Pharmacokinetics, Aqueous Dexamethasone, Inflammatory Cytokine Response.
What interventions are being tested in trial NCT04667507?
The interventions under investigation include: Dexamethasone Ophthalmic implant (DRUG).
Who is sponsoring clinical trial NCT04667507?
This trial is sponsored by Frank A. Bucci, Jr., M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04667507 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pharmacokinetics
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04667507's enrollment target sits among peer trials
102 5th of 37 higher than 33 of 37 other Pharmacokinetics trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pharmacokinetics trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy
RECRUITING · Phase 4
-
Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals
COMPLETED · Phase 4
-
Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects
COMPLETED · Phase 4
-
Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)
COMPLETED · Phase 4
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI